Abiopharma

🔍 Parker Thomas H (Executive)

Company: UR-ENERGY INC (URG)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 87,858 shares of Common Shares at $1.0405 per share (Direct)
  Date: 2026-08-25 | Code: M | equity_swap_involved: false | shares_owned_after: 668,742.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 87,858 shares of Common Shares at $1.4828 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 580,884.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 87,858 shares of Common share options (right to buy) at $1.0405 per share (Derivative)
  Date: 2026-08-25 | Code: M | Expires: 2026-08-27 | equity_swap_involved: false | shares_owned_after: 340,134.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The options were exercised and the shares were acquired at $1.44 Canadian dollars, $1.0405 U.S. dollars is the equivalent price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7226).
• F2: The shares were sold at $2.0521 Canadian dollars, $1.4828 U.S. dollars is the equivalent of the sales price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7226).
• F3: The 87,858 options were granted on 8/27/2021 and vested and became exercisable as follows: 29,286 on 8/27/2022, 29,286 on 8/27/2023; and 29,286 on 8/27/2024.